MY CLINIC
The cost of immunotherapy in the Czech Republic typically ranges from $18,000 to $32,000. Prices can vary depending on the type of cancer, the specific immunotherapy drug (such as pembrolizumab, nivolumab, or CAR-T cell therapy), the number of treatment cycles, and the clinic’s reputation. In the United States, the average cost is $30,000 (per ASCO). This means immunotherapy in the Czech Republic is about 40% less than in the U.S.
In the Czech Republic, the price usually covers initial consultations, diagnostics, drug administration, monitoring, and follow-up visits. Supportive medications and routine lab tests are often included. In the U.S., drug costs, infusions, and monitoring are frequently billed separately, and follow-up care may incur extra charges. Always confirm with your chosen clinic exactly what’s included in the quoted price.
Why choose the Czech Republic for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics .
| Czech Republic | Turkey | Austria | |
| Immunotherapy | from $18,000 | from $2,200 | from $30,000 |
| Sarcoma Immunotherapy | from $55,000 | from $3,600 | from $60,000 |
| Immunotherapy for prostate cancer | from $30,000 | from $10,000 | from $30,000 |
| Immunotherapy for lung cancer | from $30,000 | from $10,000 | from $30,000 |
| Immunotherapy for breast cancer | from $20,000 | from $10,000 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Eligible candidates for immunotherapy in Czech clinics must have confirmed diagnoses of advanced, recurrent, or metastatic cancers like melanoma or non-small cell lung cancer. Eligibility depends on biomarkers like PD-L1 expression, MSI-H status, and ECOG performance scores of 0 or 1 to ensure physical resilience.
Bookimed Expert Insight: While many European centers follow strict reimbursement limits, private Czech facilities like MY CLINIC offer more flexible pathways through direct billing with international insurers like Aetna or Allianz. This allows patients to get advanced treatments like Keytruda faster if they meet medical suitability despite local insurance restrictions.
Patient Consensus: Success depends on tumor biology rather than just the diagnosis. Ask your doctor if your specific markers or mutations qualify you for treatment.
Immunotherapy in the Czech Republic includes checkpoint inhibitors like Keytruda, biological therapies, and targeted monoclonal antibodies for oncology. Specialized centers also provide Bacillus Calmette-Guerin therapy and allergen immunotherapy for respiratory triggers. These treatments are available at accredited university hospitals in Prague and Brno.
Bookimed Expert Insight: While university hospitals handle complex oncology, private outpatient centers in Prague often provide faster access to allergen immunotherapy. These centers frequently coordinate with Charles University to offer specialized diagnostics. This path avoids the longer wait times typically found in the public healthcare system.
Patient Consensus: Patients often recommend private care in Prague for English-speaking services and quicker specialist access. The diagnostic process usually starts with an allergist consultation followed by immediate in-office testing.
Immunotherapy is covered by public health insurance in the Czech Republic for approved clinical indications. Patients must receive a prescription from an authorized specialist and approval from a tumor board. The State Institute for Drug Control (SUKL) and funds like VZP regulate these reimbursements.
Bookimed Expert Insight: While public insurance covers many treatments, accessing them often depends on clinic partnerships. For example, MY CLINIC in Prague works with international insurers like Aetna and Allianz Care. This allows patients to bypass some public system administrative delays while maintaining high safety standards under SAK accreditation.
Patient Consensus: Patients emphasize that coverage depends entirely on your exact diagnosis being on the approved list. Many note that navigating the specialist referral chain is the biggest hurdle to starting care.
Leading institutions for immunotherapy in the Czech Republic include Motol University Hospital, General University Hospital in Prague (VFN), and Masaryk Memorial Cancer Institute. These centers provide targeted biological treatments, checkpoint inhibitors like Keytruda, and clinical trials through specialized oncology departments and research units.
Bookimed Expert Insight: While private clinics like MY CLINIC offer high-standard care and SAK accreditation, they mainly focus on follow-up. For primary immunotherapy, patients benefit from large university hospitals. These institutions manage higher complexity but often require in-person scheduling at foreigner desks to avoid phone delays.
Patient Consensus: Patients trust large university hospitals like Motol or St. Anne’s for complex immunotherapy decisions despite long outpatient wait times. Preparation is vital, so bring all medical records to navigate potential referral friction at these high-demand centers.